総合病院 土浦協同病院は、茨城県土浦市おおつ野4丁目にある病院である。

During the past decade, Tsuchiura Kyodo General Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tsuchiura Kyodo General Hospital" #1 sponsor was "Bayer" with 2 trials, followed by "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored, "Japan Foundation for Neuroscience and Mental Health" with 1 trials sponsored, "Juntendo University" with 1 trials sponsored and "Massachusetts General Hospital" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tsuchiura Kyodo General Hospital" #1 collaborator was "Tsuchiura Kyodo General Hospital" with 2 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Amphia Hospital" with 1 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Tsuchiura Kyodo General Hospital" are "Atrial Fibrillation" (2 trials), "Acute Heart Failure" (1 trials), "Atherosclerosis" (1 trials), "Colorectal Cancer" (1 trials) and "Complicated Intra-abdominal Infection" (1 trials). Many other conditions were trialed in "Tsuchiura Kyodo General Hospital" in a lesser frequency.

Most popular intervention types in "Tsuchiura Kyodo General Hospital" are "Drug" (5 trials), "Other" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tsuchiura Kyodo General Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Tsuchiura Kyodo General Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Tsuchiura Kyodo General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tsuchiura Kyodo General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".